243 related articles for article (PubMed ID: 32870652)
1. Fluorescent Dopamine-Tryptophan Nanocomposites as Dual-Imaging and Antiaggregation Agents: New Generation of Amyloid Theranostics with Trimeric Effects.
Sharma M; Tiwari V; Shukla S; Panda JJ
ACS Appl Mater Interfaces; 2020 Sep; 12(39):44180-44194. PubMed ID: 32870652
[TBL] [Abstract][Full Text] [Related]
2. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
[TBL] [Abstract][Full Text] [Related]
3. Self-Fluorescent Lone Tryptophan Nanoparticles as Theranostic Agents Against Alzheimer's Disease.
Sharma M; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S; Panda JJ
ACS Appl Mater Interfaces; 2022 Mar; 14(11):13079-13093. PubMed ID: 35263093
[TBL] [Abstract][Full Text] [Related]
4. Coassembled Chitosan-Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer's β-Amyloid.
Wang W; Liu M; Gao W; Sun Y; Dong X
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55879-55889. PubMed ID: 34786930
[TBL] [Abstract][Full Text] [Related]
5. Near-Infrared Responsive Dopamine/Melatonin-Derived Nanocomposites Abrogating in Situ Amyloid β Nucleation, Propagation, and Ameliorate Neuronal Functions.
Srivastava AK; Roy Choudhury S; Karmakar S
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5658-5670. PubMed ID: 31986005
[TBL] [Abstract][Full Text] [Related]
6. Significant combination of Aβ aggregation inhibitory and neuroprotective properties in silico, in vitro and in vivo by bis(propyl)-cognitin, a multifunctional anti-Alzheimer's agent.
Hu S; Xian Y; Fan Y; Mak S; Wang J; Tang J; Pang Y; Pi R; Tsim KW; Liu F; Lin Z; Han Y
Eur J Pharmacol; 2020 Jun; 876():173065. PubMed ID: 32171792
[TBL] [Abstract][Full Text] [Related]
7. Development of novel theranostic agents for in vivo amyloid imaging and protective effects on human neuroblastoma cells.
Li Y; Yan L; Cai J; Zhang W; Li L; Du Z; Dong C; Meunier B; Chen H
Eur J Med Chem; 2019 Nov; 181():111585. PubMed ID: 31404860
[TBL] [Abstract][Full Text] [Related]
8. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K
Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693
[TBL] [Abstract][Full Text] [Related]
9. Anti-amyloidogenic amphipathic arginine-dehydrophenylalanine spheres capped selenium nanoparticles as potent therapeutic moieties for Alzheimer's disease.
Kour A; Tiwari V; Aggarwal N; Sekhar Panda H; Kumar A; Tiwari S; Chauhan VS; Shukla S; Panda JJ
Nanoscale; 2023 Aug; 15(30):12748-12770. PubMed ID: 37477348
[TBL] [Abstract][Full Text] [Related]
10. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
11. An AIE-active theranostic probe for light-up detection of Aβ aggregates and protection of neuronal cells.
Yang Y; Li S; Zhang Q; Kuang Y; Qin A; Gao M; Li F; Tang BZ
J Mater Chem B; 2019 Apr; 7(15):2434-2441. PubMed ID: 32255120
[TBL] [Abstract][Full Text] [Related]
12. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.
Scherzer-Attali R; Farfara D; Cooper I; Levin A; Ben-Romano T; Trudler D; Vientrov M; Shaltiel-Karyo R; Shalev DE; Segev-Amzaleg N; Gazit E; Segal D; Frenkel D
Neurobiol Dis; 2012 Jun; 46(3):663-72. PubMed ID: 22449754
[TBL] [Abstract][Full Text] [Related]
13. Anti-Amyloidogenic and Fibril-Disaggregating Potency of the Levodopa-Functionalized Gold Nanoroses as Exemplified in a Diphenylalanine-Based Amyloid Model.
Kour A; Dube T; Kumar A; Panda JJ
Bioconjug Chem; 2022 Feb; 33(2):397-410. PubMed ID: 35120290
[TBL] [Abstract][Full Text] [Related]
14. Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation.
Liu Y; Cong L; Han C; Li B; Dai R
Mini Rev Med Chem; 2021; 21(8):969-990. PubMed ID: 33245270
[TBL] [Abstract][Full Text] [Related]
15. Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
Huang HC; Zheng BW; Guo Y; Zhao J; Zhao JY; Ma XW; Jiang ZF
J Alzheimers Dis; 2016 Apr; 52(3):899-911. PubMed ID: 27060945
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
17. Novel sarsasapogenin-triazolyl hybrids as potential anti-Alzheimer's agents: Design, synthesis and biological evaluation.
Wang W; Wang W; Yao G; Ren Q; Wang D; Wang Z; Liu P; Gao P; Zhang Y; Wang S; Song S
Eur J Med Chem; 2018 May; 151():351-362. PubMed ID: 29635167
[TBL] [Abstract][Full Text] [Related]
18. Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease.
Ghosh N; Kundu LM
Future Med Chem; 2021 Oct; 13(20):1767-1794. PubMed ID: 34498978
[TBL] [Abstract][Full Text] [Related]
19. Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer's disease.
Kaur A; Mann S; Kaur A; Priyadarshi N; Goyal B; Singhal NK; Goyal D
Bioorg Chem; 2019 Jun; 87():572-584. PubMed ID: 30928879
[TBL] [Abstract][Full Text] [Related]
20. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]